1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ALNYLAM PHARMACEUTICALS INC

Alnylam Pharmaceuticals Inc XNAS: ALNY

Alnylam Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Momentum Trap
Download real time

250.06 -3.05 (-1.21%)

76.12% Gain from 52W Low

218.5K XNAS Volume

XNAS 18 Mar, 2025 11:52 AM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The board meeting for Alnylam Pharmaceuticals Inc is scheduled for today, for the purpose of Stifel 2025 Virtual CNS Forum See details
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
4.8 / 100
Momentum Score
Technically Neutral
44.5 / 100
Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
305
1Yr Price target upside is 22%
30 analysts

14

S

10

W

4

O

0

T

SWOT Analysis

Alnylam Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Alnylam Pharmaceuticals Inc FAQ

How is Alnylam Pharmaceuticals Inc today?
Alnylam Pharmaceuticals Inc today is trading in the red, and is down by -1.21% at 250.06.
Alnylam Pharmaceuticals Inc is currently trading down -1.21% on an intraday basis. In the past week the stock rose 7.29%. stock has been up 2.99% in the past quarter and rose 67.52% in the past year. You can view this in the overview section.